News
ImmuCell to Join Russell Microcap Index
PORTLAND, Maine, June 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for First Quarter of 2018
PORTLAND, Maine, May 14, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for First Quarter of 2018
Conference Call Scheduled for Monday, May 14, 2018 at 4:30 PM ET PORTLAND, Maine, May 07, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017
PORTLAND, Maine, Feb. 08, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017
Conference Call Scheduled for Thursday, February 8, 2018 at 4:30 PM ET PORTLAND, Maine, Feb. 05, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Appoints Two New Members to its Board of Directors
PORTLAND, Maine, Jan. 30, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock
PORTLAND, Maine, Dec. 21, 2017 -- ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
PORTLAND, Maine, Dec. 19, 2017 -- ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for Third Quarter of 2017
PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced unaudited...
ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections
PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced that the...